Association of CMV status with response to neoadjuvant chemoimmunotherapy in early triple-negative breast cancer
• CMV-positivity is associated with response to chemoimmunotherapy in early TNBC. • No such association was observed in patients receiving chemotherapy alone. • The association was independent from Ki-67 and age.
Authors
- Annette Staebler (ORCID: https://orcid.org/0000-0003-0103-6059)
- Dominik Dannehl (ORCID: https://orcid.org/0000-0002-7653-8283)
- Dorothea Hillmann
- Andreas D. Hartkopf (ORCID: https://orcid.org/0000-0003-1227-1118)
- Lorenz Risch (ORCID: https://orcid.org/0000-0003-2692-6699)
- Sara Yvonne Brucker (ORCID: https://orcid.org/0000-0001-8588-1094)
- André Koch (ORCID: https://orcid.org/0000-0003-3502-382X)
- Tobias Engler (ORCID: https://orcid.org/0000-0002-8063-2053)
- Vincent Walter (ORCID: https://orcid.org/0000-0002-7653-1161)
- Lukas Flatz (ORCID: https://orcid.org/0000-0001-9683-8390)
- Kerstin Pfister (ORCID: https://orcid.org/0009-0002-2831-1401)
- Wolfgang Janni
Institutions
- Innsbruck Medical University (AT)
- Kantonsspital St. Gallen (CH)
- University Children's Hospital Tübingen (DE)
- Labormedizinische Zentrum Dr Risch (Switzerland) (CH)
- University Hospital Ulm (DE)
Publication Details
- Journal
- Cancer Letters
- Published
- 2025-05-10
- DOI
- https://doi.org/10.1016/j.canlet.2025.217789
- Primary Topic
- Cytomegalovirus and herpesvirus research
- Type
- article
- Field-Weighted Citation Impact
- 0.00